XML 57 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Summary of Current and Deferred Components of Provision for Income Taxes for Federal, State and Foreign Jurisdictions

The current and deferred components of the provision for income taxes for federal, state and foreign jurisdictions are as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

59

 

 

 

48

 

 

 

 

Total current tax expense (benefit)

 

$

59

 

 

$

48

 

 

$

 

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

 

 

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

 

 

 

Total deferred tax expense (benefit)

 

$

 

 

$

 

 

$

 

Total tax expense (benefit)

 

$

59

 

 

$

48

 

 

$

 

 

Summary of reconciliation of the statutory federal income tax rate (benefit) and effective tax rate (benefit) A reconciliation of the U.S. statutory tax rate to our effective tax rate is presented below:

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

U.S. federal statutory income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State and local income taxes

 

 

3.2

%

 

 

4.5

%

 

 

7.4

%

R&D tax credits

 

 

5.3

%

 

 

3.1

%

 

 

5.9

%

Compensation

 

 

0.7

%

 

 

2.6

%

 

 

(5.1

)%

Warrant (gain) loss

 

 

(7.4

)%

 

 

(2.5

)%

 

 

13.0

%

Change in tax rates

 

 

0.0

%

 

 

(0.4

)%

 

 

0.4

%

Provision to return and deferred tax adjustments

 

 

0.1

%

 

 

(0.2

)%

 

 

10.9

%

Valuation allowance

 

 

(22.9

)%

 

 

(28.0

)%

 

 

(53.4

)%

Other

 

 

0.0

%

 

 

(0.1

)%

 

 

(0.1

)%

Effective tax rate

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Summary of net deferred tax assets Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

December 31,

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Accrued bonus

 

$

2,036

 

 

$

3,652

 

Unearned revenue

 

 

158

 

 

 

1,233

 

Stock-based compensation

 

 

9,793

 

 

 

7,308

 

Depreciation and amortization

 

 

3,109

 

 

 

2,843

 

Capitalized R&D costs

 

 

62,939

 

 

 

27,432

 

Lease liabilities

 

 

4,483

 

 

 

2,031

 

R&D credit carryforwards

 

 

29,800

 

 

 

11,428

 

Net operating loss carryforwards

 

 

56,204

 

 

 

36,197

 

Other

 

 

677

 

 

 

686

 

Total deferred tax assets

 

$

169,199

 

 

$

92,810

 

Valuation allowance

 

 

(166,287

)

 

 

(90,963

)

Total deferred tax assets, net of valuation allowance

 

$

2,912

 

 

$

1,847

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use assets

 

 

(2,386

)

 

 

(1,142

)

Other

 

 

(526

)

 

 

(705

)

Total deferred tax liabilities

 

$

(2,912

)

 

$

(1,847

)

Net deferred tax assets (liabilities)

 

$

 

 

$

 

Summary of valuation allowance against its gross deferred tax assets

The following table summarizes the activity in the Company’s valuation allowance against its gross deferred tax assets (in thousands):

 

 

2024

 

 

2023

 

 

2022

 

Beginning balance

 

$

90,963

 

 

$

48,212

 

 

$

20,388

 

Charged to costs and expenses

 

 

75,780

 

 

 

44,123

 

 

 

25,925

 

Charged (credited) to other accounts

 

 

(456

)

 

 

(1,372

)

 

 

1,899

 

Ending balance

 

$

166,287

 

 

$

90,963

 

 

$

48,212